期刊
ACS NANO
卷 14, 期 7, 页码 8135-8148出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsnano.0c01300
关键词
photoactivated H-2 gas; hydrogen chemotherapy; cell penetrating and transmucosal delivery; mitochondrial function; bladder cancer
类别
资金
- National Key Research and Development Program of China [2017YFA0105900]
- National Natural Science Foundation Fund of China [81672533, 81922046, 61931024]
- Special Funds for Strategic Emerging Industries Development in Shenzhen [20180309163446298]
- Innovation Program of Shenzhen [JCYJ20180508165208399]
- Guangdong Province Science and Technology Innovation Strategy Special Fund Project [2018A030310595]
- Shenzhen Key Laboratory Program [ZDSYS20190902092857146]
- China Postdoctoral Science Foundation [2018M643224]
Hydrogen gas can mitigate oxidative stress in many diseases and is regarded to be safe and free of side effects. Inspired by a metalloenzyme in a variety of microorganisms, here, we propose a photoactivated H-2 nanogenerator that comprises a fluorinated chitosan (FCS), a chemotherapeutic drug (gemcitabine, GEM), and a catalyst of H-2 production ([FeFe]TPP) that can form self-assembled [FeFe]TPP/GEM/FCS nanoparticles (NPs). The [FeFe]TPP/GEM/FCS NPs exhibit excellent transmucosal and tumor cell penetration capacities after intravesical instillation into the bladder and can efficiently produce H-2 gas in situ upon 660 nm laser irradiation, which significantly enhances the efficacy of hydrogen chemotherapy of cancer in vitro and in vivo. Moreover, we discover that H-2 gas in hydrogen chemotherapy can inhibit mitochondrial function, hinder ATP synthesis, and cause a reduction of the P-gp efflux pump function, which finally attenuates P-gp protein drug transport capacity in cancer cells. This photoactivated H-2 evolution in situ to improve the therapeutic efficacy of chemotherapy of bladder cancer may present an effective hydrogen chemotherapy strategy for cancer treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据